March 21, 2023
28 min listen
Save
Samsara Vision’s SING IMT: Game Changer for the Advanced AMD Patient
In this episode, I discuss Samsara Vision’s SING IMT and its benefits of vision improvement for patients with AMD with Rebecca Kammer, OD, PhD.
Brought to you by Alcon
- Welcome to another exciting episode of Eye Care insider :14
- Intro for Rebecca Kammer, OD, PhD :27
- Dr. Kammer’s background 1:28
- Defining late-stage AMD patients and treatments available 5:11
- The SING IMT 9:46
- US Concerto Study Website – to learn more about the study 13:13
- Visual acuity and the SING IMT 13:48
- US trial, recruitment and patient eligibility 17:18
- Contact toll-free 1-866-393-3767 discuss eligibility, participation and questions 20:39
- SING IMT as an option for patients 22:55
- Thanks for listening 27:30
We’d love to hear from you! Send your comments/questions to Dr. Mali at eyecareinsider@healio.com. Follow us on Twitter @Healio_OSN. You can reach Dr. Kammer at rkammer@samsaravision.com.
Rebecca Kammer, OD, PhD, is the vice president of worldwide clinical and medical affairs for Samsara Vision, Inc., an adjunct professor at University of California, Irvine and a diplomate in low vision of the American Academy of Optometry.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; consultant/speaker for Genentech and Roche; equity owner for SNAPS; and grant/consultant for RetinAI. Kammer reports being a clinical advisor to Biovisics and Eyedaptic.
